Literature DB >> 7213597

Nuclear magnetic resonance studies of the conformation and kinetics of the peptide-substrate at the active site of bovine heart protein kinase.

J Granot, A S Mildvan, H N Bramson, N Thomas, E T Kaiser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7213597     DOI： 10.1021/bi00506a024

Source DB:  PubMed          Journal:  Biochemistry        ISSN： 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  6 in total

1.  Conformational analysis of PKI(5-22)amide, the active inhibitory fragment of the inhibitor protein of the cyclic AMP-dependent protein kinase.

Authors:  J Reed; J S De Ropp; J Trewhella; D B Glass; W K Liddle; E M Bradbury; V Kinzel; D A Walsh
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

2.  The role of the phosphate group for the structure of phosphopeptide products of adenosine 3',5'-cyclic monophosphate-dependent protein kinase.

Authors:  R C Hider; U Ragnarsson; O Zetterqvist
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

3.  Direct effects of phosphorylation on the preferred backbone conformation of peptides: a nuclear magnetic resonance study.

Authors:  A Tholey; A Lindemann; V Kinzel; J Reed
Journal:  Biophys J       Date:  1999-01       Impact factor: 4.033

4.  Probing the peptide binding site of the cAMP-dependent protein kinase by using a peptide-based photoaffinity label.

Authors:  W T Miller; E T Kaiser
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

5.  Structures of PKA-phospholamban complexes reveal a mechanism of familial dilated cardiomyopathy.

Authors:  Juan Qin; Jingfeng Zhang; Lianyun Lin; Omid Haji-Ghassemi; Zhi Lin; Kenneth J Woycechowsky; Filip Van Petegem; Yan Zhang; Zhiguang Yuchi
Journal:  Elife       Date:  2022-03-17       Impact factor: 8.713

6.  Phosphotransferase and substrate binding mechanism of the cAMP-dependent protein kinase catalytic subunit from porcine heart as deduced from the 2.0 A structure of the complex with Mn2+ adenylyl imidodiphosphate and inhibitor peptide PKI(5-24).

Authors:  D Bossemeyer; R A Engh; V Kinzel; H Ponstingl; R Huber
Journal:  EMBO J       Date:  1993-03       Impact factor: 11.598
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.